I agree that this site is using cookies. You can find further informations here.
X
Chari, Ajai
184  results:
Articles (Online) X
Search for persons X
?
1

Phase 1 study combining elotuzumab with autologous stem cel..:

Coffey, David G ; Osman, Keren ; Aleman, Adolfo...
Journal for ImmunoTherapy of Cancer.  12 (2024)  4 - p. e008110 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Daratumumab-based quadruplet therapy for transplant-eligibl..:

Callander, Natalie S. ; Silbermann, Rebecca ; Kaufman, Jonathan L....
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Clinical Management of Patients With Relapsed/Refractory Mu..:

Chari, Ajai ; Krishnan, Amrita ; Rasche, Leo...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Health‐related quality of life in transplant‐eligible patie..:

Silbermann, Rebecca ; Laubach, Jacob ; Kaufman, Jonathan L....
American Journal of Hematology.  99 (2024)  7 - p. 1257-1268 , 2024
Link: https://doi.org/10.1002/..
 
?
5

Daratumumab in transplant-eligible patients with newly diag..:

Chari, Ajai ; Kaufman, Jonathan L. ; Laubach, Jacob...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
6

Teclistamab Improves Patient-Reported Symptoms and Health-R..:

Martin, Thomas G. ; Moreau, Philippe ; Usmani, Saad Z....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  3 - p. 194-202 , 2024
Link: https://doi.org/10.1016/..
 
?
7

GPRC5D as a novel target for the treatment of multiple myel..:

Rodriguez-Otero, Paula ; van de Donk, Niels W. C. J. ; Pillarisetti, Kodandaram...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
8

Prevalence and impact of diabetes on survival of patients w..:

Shah, Urvi A. ; Moshier, Erin ; Derkach, Andriy...
Blood Advances.  8 (2024)  1 - p. 236-247 , 2024
Link: https://doi.org/10.1182/..
 
?
9

Correction: GPRC5D as a novel target for the treatment of m..:

Rodriguez-Otero, Paula ; van de Donk, Niels W. C. J. ; Pillarisetti, Kodandaram...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
10

Post hoc analysis of daratumumab plus lenalidomide, bortezo..:

Nooka, Ajay K. ; Kaufman, Jonathan L. ; Rodriguez, Cesar...
British Journal of Haematology.  204 (2024)  6 - p. 2227-2232 , 2024
Link: https://doi.org/10.1111/..
 
?
11

Salvage therapies including retreatment with BCMA-directed ..:

Reyes, Kevin R. ; Liu, Yen-Chun ; Huang, Chiung-Yu...
Blood Advances.  8 (2024)  9 - p. 2207-2216 , 2024
Link: https://doi.org/10.1182/..
 
?
12

P-043 Leveraging wearable devices for remote patient monito..:

Rajeeve, Sridevi ; Wilkes, Matt ; Zahradka, Nicole...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S58 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P881: DURABILITY OF RESPONSES WITH BIWEEKLY DOSING OF TECLI..:

Bhutani, Manisha ; Garfall, Alfred ; Uttervall, Katarina...
HemaSphere.  7 (2023)  S3 - p. e90600b0 , 2023
Link: https://doi.org/10.1097/..
 
?
14

Corticosteroid tapering is a safe approach in patients with..:

Nahi, Hareth ; Usmani, Saad Z. ; Mateos, Maria-Victoria...
Leukemia & Lymphoma.  64 (2023)  2 - p. 468-472 , 2023
Link: https://doi.org/10.1080/..
 
?
15

P-023 Talquetamab, a G protein–coupled receptor family C gr..:

Krishnan, Amrita ; Costa, Luciano ; Schinke, Carolina...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S45-S46 , 2023
Link: https://doi.org/10.1016/..
 
1-15